SI3778609T1 - Derivati penama ali njenih soli, farmacevtski sestavki in njihova uporaba - Google Patents
Derivati penama ali njenih soli, farmacevtski sestavki in njihova uporabaInfo
- Publication number
- SI3778609T1 SI3778609T1 SI201930168T SI201930168T SI3778609T1 SI 3778609 T1 SI3778609 T1 SI 3778609T1 SI 201930168 T SI201930168 T SI 201930168T SI 201930168 T SI201930168 T SI 201930168T SI 3778609 T1 SI3778609 T1 SI 3778609T1
- Authority
- SI
- Slovenia
- Prior art keywords
- salts
- pharmaceutical compositions
- penam derivatives
- penam
- derivatives
- Prior art date
Links
- 150000002959 penams Chemical class 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D499/21—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a nitrogen atom directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D499/44—Compounds with an amino radical acylated by carboxylic acids, attached in position 6
- C07D499/76—Compounds with an amino radical acylated by carboxylic acids, attached in position 6 with hetero rings directly attached to the carboxamido radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D499/21—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a nitrogen atom directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D499/44—Compounds with an amino radical acylated by carboxylic acids, attached in position 6
- C07D499/48—Compounds with an amino radical acylated by carboxylic acids, attached in position 6 with a carbon chain, substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, attached to the carboxamido radical
- C07D499/58—Compounds with an amino radical acylated by carboxylic acids, attached in position 6 with a carbon chain, substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, attached to the carboxamido radical substituted in alpha-position to the carboxamido radical
- C07D499/64—Compounds with an amino radical acylated by carboxylic acids, attached in position 6 with a carbon chain, substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, attached to the carboxamido radical substituted in alpha-position to the carboxamido radical by nitrogen atoms
- C07D499/70—Compounds with an amino radical acylated by carboxylic acids, attached in position 6 with a carbon chain, substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, attached to the carboxamido radical substituted in alpha-position to the carboxamido radical by nitrogen atoms with hetero rings as additional substituents on the carbon chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D499/897—Compounds with substituents other than a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
- A61K31/431—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems containing further heterocyclic rings, e.g. ticarcillin, azlocillin, oxacillin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018073568 | 2018-04-06 | ||
| EP19781624.2A EP3778609B1 (en) | 2018-04-06 | 2019-04-05 | Penam derivatives or salts thereof, pharmaceutical compositions and use thereof |
| PCT/JP2019/015176 WO2019194306A1 (ja) | 2018-04-06 | 2019-04-05 | 新規なペナム誘導体又はその塩、医薬組成物及びその応用 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI3778609T1 true SI3778609T1 (sl) | 2022-06-30 |
Family
ID=68100759
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI201930168T SI3778609T1 (sl) | 2018-04-06 | 2019-04-05 | Derivati penama ali njenih soli, farmacevtski sestavki in njihova uporaba |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20210024543A1 (sl) |
| EP (1) | EP3778609B1 (sl) |
| JP (1) | JP7092869B2 (sl) |
| KR (1) | KR102442994B1 (sl) |
| CN (1) | CN111954673B (sl) |
| AU (1) | AU2019249008B2 (sl) |
| CA (1) | CA3096177C (sl) |
| CY (1) | CY1125078T1 (sl) |
| DK (1) | DK3778609T3 (sl) |
| ES (1) | ES2908044T3 (sl) |
| HR (1) | HRP20220408T1 (sl) |
| LT (1) | LT3778609T (sl) |
| PL (1) | PL3778609T3 (sl) |
| PT (1) | PT3778609T (sl) |
| RS (1) | RS63060B1 (sl) |
| SI (1) | SI3778609T1 (sl) |
| TW (1) | TWI795549B (sl) |
| WO (1) | WO2019194306A1 (sl) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102657446B1 (ko) * | 2021-09-27 | 2024-04-17 | 서울대학교산학협력단 | 항균용 조성물 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH089627B2 (ja) * | 1986-12-23 | 1996-01-31 | 富山化学工業株式会社 | 新規なペナム誘導体またはその塩 |
| AU627895B2 (en) * | 1989-06-22 | 1992-09-03 | Toyama Chemical Co. Ltd. | Novel penam derivatives and salts thereof, processes for producing the same and antibacterial agent comprising the same |
| JP2973126B2 (ja) * | 1989-06-22 | 1999-11-08 | 富山化学工業株式会社 | 新規なペナム誘導体およびその塩 |
| JP3523664B2 (ja) * | 1992-05-18 | 2004-04-26 | 富山化学工業株式会社 | 新規なペナム誘導体またはその塩 |
| JPH10130272A (ja) * | 1996-10-25 | 1998-05-19 | Toyama Chem Co Ltd | ２−カルボキシペナム誘導体またはその塩の製造法 |
| JP2936404B2 (ja) | 1998-01-16 | 1999-08-23 | 富山化学工業株式会社 | ペナム−３−カルボン酸誘導体の製造法およびペナム−２，３−ジカルボン酸誘導体 |
| TWI547496B (zh) * | 2011-10-04 | 2016-09-01 | 葛蘭素集團公司 | 抗菌化合物 |
| US9751894B2 (en) * | 2015-12-10 | 2017-09-05 | Naeja-Rgm Pharmaceuticals Inc. | Cephem compounds, their production and use |
-
2019
- 2019-04-03 TW TW108111972A patent/TWI795549B/zh active
- 2019-04-05 HR HRP20220408TT patent/HRP20220408T1/hr unknown
- 2019-04-05 AU AU2019249008A patent/AU2019249008B2/en active Active
- 2019-04-05 WO PCT/JP2019/015176 patent/WO2019194306A1/ja active Application Filing
- 2019-04-05 EP EP19781624.2A patent/EP3778609B1/en active Active
- 2019-04-05 PT PT197816242T patent/PT3778609T/pt unknown
- 2019-04-05 LT LTEPPCT/JP2019/015176T patent/LT3778609T/lt unknown
- 2019-04-05 KR KR1020207028336A patent/KR102442994B1/ko active IP Right Grant
- 2019-04-05 RS RS20220298A patent/RS63060B1/sr unknown
- 2019-04-05 JP JP2020512335A patent/JP7092869B2/ja active Active
- 2019-04-05 PL PL19781624T patent/PL3778609T3/pl unknown
- 2019-04-05 CA CA3096177A patent/CA3096177C/en active Active
- 2019-04-05 SI SI201930168T patent/SI3778609T1/sl unknown
- 2019-04-05 DK DK19781624.2T patent/DK3778609T3/da active
- 2019-04-05 CN CN201980024184.6A patent/CN111954673B/zh active Active
- 2019-04-05 ES ES19781624T patent/ES2908044T3/es active Active
-
2020
- 2020-10-05 US US17/063,110 patent/US20210024543A1/en active Pending
-
2022
- 2022-03-16 CY CY20221100209T patent/CY1125078T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HRP20220408T1 (hr) | 2022-05-27 |
| EP3778609A1 (en) | 2021-02-17 |
| KR20200128556A (ko) | 2020-11-13 |
| CY1125078T1 (el) | 2024-02-16 |
| LT3778609T (lt) | 2022-04-25 |
| CN111954673A (zh) | 2020-11-17 |
| PT3778609T (pt) | 2022-03-02 |
| DK3778609T3 (da) | 2022-03-14 |
| JP7092869B2 (ja) | 2022-06-28 |
| WO2019194306A1 (ja) | 2019-10-10 |
| AU2019249008B2 (en) | 2021-11-11 |
| EP3778609B1 (en) | 2022-01-26 |
| CN111954673B (zh) | 2023-09-05 |
| RS63060B1 (sr) | 2022-04-29 |
| EP3778609A4 (en) | 2021-02-17 |
| CA3096177A1 (en) | 2019-10-10 |
| AU2019249008A1 (en) | 2020-10-22 |
| CA3096177C (en) | 2023-12-12 |
| JPWO2019194306A1 (ja) | 2021-03-11 |
| TWI795549B (zh) | 2023-03-11 |
| KR102442994B1 (ko) | 2022-09-13 |
| PL3778609T3 (pl) | 2022-04-25 |
| TW202005969A (zh) | 2020-02-01 |
| US20210024543A1 (en) | 2021-01-28 |
| ES2908044T3 (es) | 2022-04-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL257481B (en) | Substituted quinolone derivatives, or pharmaceutically acceptable salts or stereoisomers thereof, and pharmaceutical compositions and use thereof | |
| ZA201906451B (en) | 4-pyridone compound or salt thereof, and pharmaceutical composition and formulation including same | |
| IL283539A (en) | 3,3-difluoroallylamines or their salts and pharmaceutical preparations containing them | |
| IL282428A (en) | History of pyridinyl sulfonamide, pharmaceutical preparations and their uses | |
| EP3894408A4 (en) | TRIAZOLOPYRIDIN-3-ONE OR THEIR SALTS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| HK1256674A1 (zh) | 氘修飾的brigatinib衍生物、含有該化合物的藥物組合物及其用途 | |
| EP3421038A4 (en) | Naphthyridine compound, pharmaceutical composition and use thereof | |
| IL267829B (en) | History of new amino-imidazopyridines as Janus kinase inhibitors and their pharmaceutical use | |
| GB2590189B (en) | Lycorine derivative, and pharmaceutical composition and use thereof | |
| PT3632436T (pt) | Composição farmacêutica compreendendo sais de lenvatinib | |
| IL274868A (en) | History of imidazopyridine and their use as medicine | |
| LT3778609T (lt) | Penamo dariniai arba jo druskos, farmacinės kompozicijos ir jų naudojimas | |
| IL282142A (en) | The history of 4-pyrazine-2-ylmethyl-morpholine and its use as a medicine | |
| EP3604291A4 (en) | COMPOUND OR SALT THEREOF, ANTIVIRAL AGENT AND PHARMACEUTICAL COMPOSITION | |
| PL3980403T3 (pl) | Sole montelukastu i zawierające je kompozycje farmaceutyczne | |
| EP3816165A4 (en) | NEW SUBSTITUTED 9N ADENINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND USE THEREOF | |
| EP3326631A4 (en) | PAC-1 COMPOUND OR SALT THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME |